A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

Hollywood actress Amy Schumer has opened up about her experience using the popular Type 2 diabetes drug, Ozempic.

Even really skinny people like to be on Ozempic, especially these people in Hollywood because they don’t get hungry,” says one plastic surgeon.

I consulted a dietician and a psychologist to find out about this so-called “Ozempic personality.” Related: What Happens When You Take Ozempic for Weight Loss? An Endocrinologist, Aesthetic Medicine ...

Ozempic and Wegovy are among the 15 additional drugs selected for a list that will be negotiated for lower Medicare prices. Ten other drugs have already been selected for the Medicare list in an ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

Blockbuster diabetes drug Ozempic is on the list ... the first batch of negotiated Medicare drug prices in August after negotiating them for months. Those 10 lower prices – which ranged from ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy ... as the drug is expected to face generic competition before the negotiated price kicks in.

Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden ...

It's the second year in a row that Medicare will negotiate drug prices after the Inflation Reduction Act authorized it to do so in 2022. Blockbuster weight loss drug Ozempic could get cheaper by ...

The White House on Friday said Novo Nordisk's weight-loss drugs Wegovy and Ozempic were among the 15 ... but if they don't, they face fines or the possible end of Medicare reimbursements.